bunazosin has been researched along with Insulin Sensitivity in 3 studies
bunazosin: structure
Excerpt | Relevance | Reference |
---|---|---|
" We investigated the effect of a slow-release alpha1-receptor blocker, bunazosin hydrochloride, on leptin levels and insulin resistance in obese hypertensive patients with hyperleptinemia." | 9.12 | An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia. ( Ihara, S; Kawana, M; Sakai, R; Shimamoto, K; Watanabe, H, 2006) |
"To investigate insulin insensitivity and its reversibility, we performed an insulin sensitivity test using the steady state plasma glucose (SSPG) method in 10 lean hypertensive subjects with normal glucose tolerance before and after treatment with alpha 1-blocker bunazosin, and 14 age body mass index-adjusted healthy control subjects." | 7.68 | Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin). ( Asakura, Y; Harano, Y; Hirose, J; Kageyama, A; Omae, T; Sato, A; Suzuki, M, 1992) |
" We investigated the effect of a slow-release alpha1-receptor blocker, bunazosin hydrochloride, on leptin levels and insulin resistance in obese hypertensive patients with hyperleptinemia." | 5.12 | An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia. ( Ihara, S; Kawana, M; Sakai, R; Shimamoto, K; Watanabe, H, 2006) |
"To investigate insulin insensitivity and its reversibility, we performed an insulin sensitivity test using the steady state plasma glucose (SSPG) method in 10 lean hypertensive subjects with normal glucose tolerance before and after treatment with alpha 1-blocker bunazosin, and 14 age body mass index-adjusted healthy control subjects." | 3.68 | Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin). ( Asakura, Y; Harano, Y; Hirose, J; Kageyama, A; Omae, T; Sato, A; Suzuki, M, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ihara, S | 1 |
Shimamoto, K | 1 |
Watanabe, H | 1 |
Sakai, R | 1 |
Kawana, M | 1 |
Harano, Y | 2 |
Suzuki, M | 2 |
Shinozaki, K | 1 |
Hara, Y | 1 |
Ryomoto, K | 1 |
Kanazawa, A | 1 |
Nishioheda, Y | 1 |
Tsushima, M | 1 |
Hirose, J | 1 |
Asakura, Y | 1 |
Sato, A | 1 |
Kageyama, A | 1 |
Omae, T | 1 |
1 trial available for bunazosin and Insulin Sensitivity
Article | Year |
---|---|
An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; | 2006 |
2 other studies available for bunazosin and Insulin Sensitivity
Article | Year |
---|---|
Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blo | 1996 |
Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Apoproteins; Blood Glucose; Blood Pressure; Catecholamine | 1992 |